Implementing Measurement-Based Care to Determine and Treat Inadequate Response

View This PDF

NB: This article is only available as a PDF.

​​

Measurement-based care (MBC) is an important strategy in the treatment of patients with major depressive disorder who have inadequate antidepressant response. The rating scales used in MBC can assist clinicians at critical decision points, such as when to declare a treatment failure, what to do with partial improvement, and how long to continue successful treatment. Measurement has two benefits: it gives the clinician an objective basis for comparison of symptom severity over time, and it helps patients to have insight into their illness course. Further, many of these tools do not add substantially to the length of the clinical visit. MBC can also be used to monitor and address residual symptoms such as fatigue and irritability that impact patients’ functioning and quality of life.​

See the entire activity.​​​​​

J Clin Psychiatry 2020;81(3):OT19037BR1

https://doi.org/10.4088/JCP.OT19037BR1